{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:39:26Z","timestamp":1773247166386,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1097\/00000441-200312000-00012","type":"journal-article","created":{"date-parts":[[2003,12,4]],"date-time":"2003-12-04T09:04:47Z","timestamp":1070528687000},"page":"360-368","source":"Crossref","is-referenced-by-count":13,"title":["Current Issues in the Management of Bacterial Respiratory Tract Disease: The Challenge of Antibacterial Resistance"],"prefix":"10.1016","volume":"326","author":[{"given":"Lala M.","family":"Dunbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-200312000-00012_bb0010","first-page":"447","article-title":"Global and regional cause-of-death patterns in 1990","volume":"72","author":"Murray","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1097\/00000441-200312000-00012_bb0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1067\/mem.2000.109341","article-title":"Antibiotic prescribing for patients with colds, upper respiratory tract infections, and bronchitis: a national study of hospital-based emergency departments","volume":"36","author":"Stone","year":"2000","journal-title":"Ann Emerg Med"},{"key":"10.1097\/00000441-200312000-00012_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1097\/00000441-200312000-00012_bb0025","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/320181","article-title":"Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997\u20131999","volume":"32","author":"Hoban","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1097\/00000441-200312000-00012_bb0030","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"American Thoracic Society","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1097\/00000441-200312000-00012_bb0035","first-page":"S42","article-title":"Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones","volume":"4","author":"Rubinstein","year":"1998","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"10.1097\/00000441-200312000-00012_bb0040","first-page":"S8","article-title":"The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory pathogens","volume":"4","author":"Goldstein","year":"1998","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"10.1097\/00000441-200312000-00012_bb0045","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/00003246-200104001-00011","article-title":"Impact of antibiotic resistance on clinical outcomes and the cost of care","volume":"29","author":"Niederman","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1097\/00000441-200312000-00012_bb0050","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/00007611-200093090-00001","article-title":"Confronting the problem of increasing antibiotic resistance","volume":"93","author":"Hellinger","year":"2000","journal-title":"South Med J"},{"key":"10.1097\/00000441-200312000-00012_bb0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.45.4.1037-1042.2001","article-title":"Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0060","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1179\/joc.1999.11.Supplement-2.35","article-title":"Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?","volume":"11","author":"Baquero","year":"1999","journal-title":"J Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/AAC.43.2.385","article-title":"Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)","volume":"43","author":"Doern","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/AAC.41.2.292","article-title":"Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of \u03b2-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study","volume":"41","author":"Doern","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0732-8893(96)00219-2","article-title":"A 1994\u20131995 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States","volume":"27","author":"Jones","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"10.1097\/00000441-200312000-00012_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-199958002-00123","article-title":"Surveillance of antimicrobial resistance among respiratory tract pathogens in the United States 1997\u20131998","volume":"58","author":"Thornsberry","year":"1999","journal-title":"Drugs"},{"key":"10.1097\/00000441-200312000-00012_bb0090","unstructured":"PROTEKT Newsletter 2000:1(1). Micron Publishing, Cambs, UK."},{"issue":"Suppl","key":"10.1097\/00000441-200312000-00012_bb0095","first-page":"S15","article-title":"Mechanisms and patterns of antibiotic resistance in respiratory pathogens","volume":"23","author":"Stratton","year":"2002","journal-title":"J Respir Dis"},{"key":"10.1097\/00000441-200312000-00012_bb0100","article-title":"In vitro activity of telithromycin against clinical isolates of Streptococcus pneumoniae collected from medical centers across the United States during the winter of 2000\/2001","author":"Stratton","year":"2001"},{"key":"10.1097\/00000441-200312000-00012_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/48.suppl_2.1","article-title":"Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site","volume":"48","author":"Douthwaite","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1097\/00000441-200312000-00012_bb0110","doi-asserted-by":"crossref","first-page":"2S19","DOI":"10.1111\/j.1469-0691.1998.tb00691.x","article-title":"Epidemiology and mechanisms of resistance among respiratory tract pathogens","volume":"4","author":"Baquero","year":"1998","journal-title":"Clin Microbiol Infect"},{"key":"10.1097\/00000441-200312000-00012_bb0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.294.5543.759","article-title":"Researchers question obsession with Cipro","volume":"294","author":"Enserink","year":"2001","journal-title":"Science"},{"issue":"Suppl 3","key":"10.1097\/00000441-200312000-00012_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1469-0691.2001.0070s3002.x","article-title":"Microbiological profile of telithromycin, the first ketolide antimicrobial","volume":"7","author":"Felmingham","year":"2001","journal-title":"Clin Microb Infect"},{"key":"10.1097\/00000441-200312000-00012_bb0125","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the definition of susceptibility of Streptococcus pneumoniae to \u03b2-lactam antibiotics","volume":"161","author":"Musher","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200312000-00012_bb0130","article-title":"Macrolide resistance: a threat to controlling respiratory tract infections","author":"Garber","year":"2001"},{"issue":"Suppl","key":"10.1097\/00000441-200312000-00012_bb0135","first-page":"S6","article-title":"The evolving world of respiratory tract infections","volume":"23","author":"File","year":"2002","journal-title":"J Respir Dis"},{"issue":"Suppl 3","key":"10.1097\/00000441-200312000-00012_bb0140","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/ajhp\/56.suppl_3.S16","article-title":"Using pharmacodynamic and pharmacokinetic surrogate markers in clinical practice: optimizing antimicrobial therapy in respiratory-tract infections","volume":"56","author":"Nicolau","year":"1999","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1097\/00000441-200312000-00012_bb0145","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"261","article-title":"Penicillins","author":"Chambers","year":"2000"},{"key":"10.1097\/00000441-200312000-00012_bb0150","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"336","article-title":"Tetracycline and chloramphenicol","author":"Standiford","year":"2000"},{"key":"10.1097\/00000441-200312000-00012_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1179\/joc.1997.9.3.167","article-title":"Amoxicillin clavulanate: an assessment after 15years of clinical application","volume":"9","author":"Ball","year":"1997","journal-title":"J Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0160","series-title":"Management of respiratory tract infections","author":"Bartlett","year":"1999"},{"issue":"Suppl 1","key":"10.1097\/00000441-200312000-00012_bb0165","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/324525","article-title":"Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program 1999\u20132000","volume":"34","author":"Thornsberry","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1097\/00000441-200312000-00012_bb0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1005592225244","article-title":"Evaluation of community-acquired pneumonia guidelines","volume":"24","author":"Ravago","year":"2000","journal-title":"J Med Syst"},{"key":"10.1097\/00000441-200312000-00012_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0924-8579(00)00252-1","article-title":"The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia","volume":"16","author":"Garcia-Rodriguez","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1097\/00000441-200312000-00012_bb0180","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200312000-00012_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/AAC.33.3.277","article-title":"In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection","volume":"33","author":"Gladue","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl E","key":"10.1097\/00000441-200312000-00012_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_E.39","article-title":"Selection of dose regimens of azithromycin","volume":"31","author":"Foulds","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 12","key":"10.1097\/00000441-200312000-00012_bb0195","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200262120-00006","article-title":"The ketolides: a critical review","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"10.1097\/00000441-200312000-00012_bb0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/48.suppl_2.25","article-title":"Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens","volume":"48","author":"Hammerschlag","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 3","key":"10.1097\/00000441-200312000-00012_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1469-0691.2001.0070s3024.x","article-title":"Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin","volume":"7","author":"Drusano","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1097\/00000441-200312000-00012_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/AAC.45.1.23-29.2001","article-title":"Pharmacodynamics of telithromycin in vitro against respiratory tract pathogens","volume":"45","author":"Odenholt","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0215","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dkf062","article-title":"Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration","volume":"49","author":"Namour","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/47.6.837","article-title":"Lung concentrations of telithromycin after oral dosing","volume":"47","author":"Khair","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s15010-002-2096-z","article-title":"Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia","volume":"30","author":"Hagberg","year":"2002","journal-title":"Infection"},{"key":"10.1097\/00000441-200312000-00012_bb0230","unstructured":"Briefing document for the FDA\/Ketek (telithromycin) tablets. Last update: 2003. Available at: URL: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/briefing\/3919B1_01_Aventis-KETEK.pdf."},{"key":"10.1097\/00000441-200312000-00012_bb0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1742-1241.2003.tb10511.x","article-title":"Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults","volume":"57","author":"Pullman","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1097\/00000441-200312000-00012_bb0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/147323000303100301","article-title":"Oral telithromycin 800mg once daily for 5days versus cefuroxime axetil 500mg twice daily for 10days in adults with acute exacerbations of chronic bronchitis","volume":"31","author":"Zervos","year":"2003","journal-title":"J Int Med Res"},{"key":"10.1097\/00000441-200312000-00012_bb0245","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/rmed.2002.1382","article-title":"Telithromycin is as effective as amoxicillin\/clavulanate in acute exacerbations of chronic bronchitis","volume":"96","author":"Aubier","year":"2002","journal-title":"Respir Med"},{"key":"10.1097\/00000441-200312000-00012_bb0250","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/014556130308200812","article-title":"Efficacy and tolerability of telithromycin for 5 or 10days vs amoxicillin\/clavulanic acid for 10days in the treatment of acute maxillary sinsusitis","volume":"87","author":"Luterman","year":"2003","journal-title":"Ear Nose Throat J"},{"key":"10.1097\/00000441-200312000-00012_bb0255","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/48.3.407","article-title":"In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae","volume":"48","author":"Weiss","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1-2","key":"10.1097\/00000441-200312000-00012_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0732-8893(01)00249-8","article-title":"In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens","volume":"40","author":"Dubois","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1Suppl 2","key":"10.1097\/00000441-200312000-00012_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1568005014606071","article-title":"The emerging new generation of antibiotic: ketolides","author":"Zhong","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1097\/00000441-200312000-00012_bb0270","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/jac\/dkg154","article-title":"Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community acquired pneumonia due to Chlamydia pneumoniae","volume":"51","author":"Hammerschlag","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1097\/00000441-200312000-00012_bb0275","first-page":"766","article-title":"ABT-773 (Abbott Laboratories)","volume":"6","author":"Lawrence","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1097\/00000441-200312000-00012_bb0280","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/AAC.45.9.2585-2593.2001","article-title":"Efficacies of ABT-773, a new ketolide, against experimental bacterial infections","volume":"45","author":"Mitten","year":"2001","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915341690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915341690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T15:33:52Z","timestamp":1704987232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915341690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0002962915341690"],"URL":"https:\/\/doi.org\/10.1097\/00000441-200312000-00012","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}